William Maughan
Stock Analyst at Clear Street
(4.38)
# 1,233
Out of 4,579 analysts
140
Total ratings
44.4%
Success rate
15.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Maintained: Buy | $338 → $311 | $351.82 | -11.60% | 5 | May 4, 2026 | |
| SMMT Summit Therapeutics | Maintained: Buy | $32 → $31 | $13.11 | +136.55% | 6 | May 1, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $39 → $36 | $5.92 | +508.11% | 7 | Apr 28, 2026 | |
| ANNX Annexon | Maintained: Buy | $17 | $5.13 | +231.38% | 2 | Mar 30, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $37 | $25.07 | +47.59% | 5 | Mar 25, 2026 | |
| CLLS Cellectis | Maintained: Buy | $9 | $2.89 | +211.42% | 2 | Mar 20, 2026 | |
| KRRO Korro Bio | Maintained: Buy | $18 | $10.72 | +67.91% | 5 | Mar 13, 2026 | |
| IPSC Century Therapeutics | Maintained: Buy | $6.6 | $2.09 | +215.79% | 10 | Mar 13, 2026 | |
| MOLN Molecular Partners AG | Maintained: Buy | $8 | $4.01 | +99.75% | 4 | Mar 13, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $181 → $167 | $91.09 | +83.34% | 21 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.6 | $2.68 | +71.64% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $130 | $104.49 | +24.41% | 2 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $9.71 | +363.44% | 4 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $1.59 | +717.61% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $28 | $8.64 | +224.07% | 6 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $27 | $11.94 | +126.13% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $50 | $46.73 | +7.00% | 4 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $67 | $33.77 | n/a | 4 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $12.01 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $9 | $2.43 | n/a | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $19.86 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $2.26 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 → $106 | $55.63 | n/a | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $3.95 | n/a | 7 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $5 | $34.62 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $200.14 | n/a | 1 | Sep 5, 2022 |
Krystal Biotech
May 4, 2026
Maintained: Buy
Price Target: $338 → $311
Current: $351.82
Upside: -11.60%
Summit Therapeutics
May 1, 2026
Maintained: Buy
Price Target: $32 → $31
Current: $13.11
Upside: +136.55%
Wave Life Sciences
Apr 28, 2026
Maintained: Buy
Price Target: $39 → $36
Current: $5.92
Upside: +508.11%
Annexon
Mar 30, 2026
Maintained: Buy
Price Target: $17
Current: $5.13
Upside: +231.38%
Beam Therapeutics
Mar 25, 2026
Maintained: Buy
Price Target: $37
Current: $25.07
Upside: +47.59%
Cellectis
Mar 20, 2026
Maintained: Buy
Price Target: $9
Current: $2.89
Upside: +211.42%
Korro Bio
Mar 13, 2026
Maintained: Buy
Price Target: $18
Current: $10.72
Upside: +67.91%
Century Therapeutics
Mar 13, 2026
Maintained: Buy
Price Target: $6.6
Current: $2.09
Upside: +215.79%
Molecular Partners AG
Mar 13, 2026
Maintained: Buy
Price Target: $8
Current: $4.01
Upside: +99.75%
BioNTech SE
Mar 11, 2026
Reiterated: Buy
Price Target: $181 → $167
Current: $91.09
Upside: +83.34%
Mar 10, 2026
Maintained: Buy
Price Target: $4.6
Current: $2.68
Upside: +71.64%
Mar 10, 2026
Reiterated: Buy
Price Target: $100 → $130
Current: $104.49
Upside: +24.41%
Mar 6, 2026
Reiterated: Buy
Price Target: $45
Current: $9.71
Upside: +363.44%
Mar 6, 2026
Maintained: Buy
Price Target: $13
Current: $1.59
Upside: +717.61%
Mar 2, 2026
Maintained: Buy
Price Target: $21 → $28
Current: $8.64
Upside: +224.07%
Feb 26, 2026
Maintained: Buy
Price Target: $29 → $27
Current: $11.94
Upside: +126.13%
Nov 11, 2025
Maintained: Hold
Price Target: $45 → $50
Current: $46.73
Upside: +7.00%
May 23, 2024
Maintained: Hold
Price Target: $67
Current: $33.77
Upside: n/a
May 15, 2024
Maintained: Buy
Price Target: $24
Current: $12.01
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $11 → $9
Current: $2.43
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $38
Current: $19.86
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $16 → $15
Current: $2.26
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $91 → $106
Current: $55.63
Upside: n/a
Feb 20, 2024
Maintained: Buy
Price Target: $60
Current: $3.95
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $10 → $5
Current: $34.62
Upside: n/a
Sep 5, 2022
Reiterated: Buy
Price Target: n/a
Current: $200.14
Upside: n/a